|
【结 构 式】 
|
【分子编号】58362 【品名】(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-10,14,17,17-tetramethyl-9-[(3-methyl-3-sulfanylbutanoyl)oxy]-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate 【CA登记号】 |
【 分 子 式 】C52H59NO15S 【 分 子 量 】970.1042 【元素组成】C 64.38% H 6.13% N 1.44% O 24.74% S 3.31% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(VI)The trichloroethyl carbonate ester of (V) is then reductively cleaved using zinc dust and HOAc, to produce (VI). Finally, nitrosation of the thiol group of (VI) by means of t-butyl nitrite furnishes the target nitrosothio derivative.
| 【1】 Lin, C.-E.; et al.; Design and synthesis of nitrosylated paclitaxel (NO-paclitaxel) and adamantanyl nitric oxide donor as antirestenosis agents. 223rd ACS Natl Meet (April 7 2002, Orlando) 2002, Abst MEDI 36. |
| 【2】 Garvey, D.S.; Letts, L.G.; Wang, T.; Richardson, S.K.; Lin, C.-E. (NitroMed Inc.); Nitrosated and nitrosylated taxanes, compsns. and methods of use. WO 0198286 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (V) | 58361 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-[((2R,3S)-3-(benzoylamino)-3-phenyl-2-{[(2,2,2-trichloroethoxy)carbonyl]oxy}propanoyl)oxy]-1-hydroxy-10,14,17,17-tetramethyl-9-[(3-methyl-3-sulfanylbutanoyl)oxy]-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate | C55H60Cl3NO17S | 详情 | 详情 | |
| (VI) | 58362 | (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-10,14,17,17-tetramethyl-9-[(3-methyl-3-sulfanylbutanoyl)oxy]-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate | C52H59NO15S | 详情 | 详情 |
Extended Information